KalVista Pharmaceuticals creating a new generation of small molecule protease inhibitors for HAE and DME Hereditary Angioedema (HAE)Diabetic Macular Edema (DME)
News KalVista Pharmaceuticals Provides Business Update Nov 13, 2019 KalVista Pharmaceuticals to Present at Cantor Global Healthcare Conference Sep 26, 2019 KalVista Pharmaceuticals Reports Fiscal First Quarter Results Sep 9, 2019 All News
